Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human plasma-derived alpha-1 proteinase inhibitor

EU orphan designation number: EU/3/15/1455   
Active ingredient: Human plasma-derived alpha-1 proteinase inhibitor
Indication: Treatment of graft-versus-host disease
Sponsor: Kamada BioPharma Limited
Riverbank House, 2 Swan Lane, London EC4R 3TT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/267/14 (2015)2021 of 19/03/2015
28/09/2016 Transfer of orphan designation EMA/OD/267/14 (2016) 6307 of 26/09/2016